Plasma carnitine ester profile in Crohn's disease
Zeitschrift für Gastroenterologie2004Vol. 42(05)
Károly Horváth, Beáta Gasztonyi, Judit Bene, Katalin Komlósi, V. Havasi, Gábor Talián, V Vélin, S Varjú, Márk Juhász, Zsolt Tulassay, I. Juricskay, Gy. Mózsik, B Hunyady, Béla Melegh
Abstract
Background: Very recent data show that the human OCTN1 and OCTN2 carnitine (C) transporter orthologs likely map to the IBD5 locus at 5q31, which has been suggested to confer susceptibility to Crohn's disease (CD). Therefore, a link between a pathogenic role of C and the CD can exist. The circulating C ester profile has not been investigated in CD.
Related Papers
- → Primary and secondary alterations of neonatal carnitine metabolism(1999)89 cited
- → A Child With Valproic Acid-Associated Carnitine Deficiency and Carnitine-Responsive Cardiac Dysfunction(1992)17 cited
- → Carnitine deficiency in surgical neonates receiving total parenteral nutrition(1990)26 cited
- → Plasma and red blood cell carnitine and carnitine esters during L-carnitine therapy in hemodialysis patients(1990)23 cited
- → Tissue carnitine concentrations after total parenteral nutrition with and without L-carnitine supplementation(1983)11 cited